A Critique of the International Consensus Statement on ADHD

  • Sami Timimi
  • 33 Coendorsers
ADHD international consensus critique 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Barkley, R. et al. (2002). International Consensus Statement on ADHD. Clinical Child and Family Psychology Review, 5, 89-111.Google Scholar
  2. Baumeister, A. A., & Hawkins, M. F. (2001). Incoherence of neuroimaging studies in attention deficit/hyperactivity disorder. Clinical Neuropharmacology, 24, 2-10.Google Scholar
  3. Biederman, J., Newcorn, J., & Sprich, S. (1991). Comorbidity of attention deficit disorder with conduct, depressive, anxiety and other disorders. American Journal of Psychiatry, 148, 564-577.Google Scholar
  4. Breggin, P. (1999). Psychostimulants in the treatment of children diagnosed with ADHD: Part II—Adverse effects on brain and behavior. Ethical Human Sciences and Services, 1, 213-241.Google Scholar
  5. Breggin, P. (2000). Reclaiming our children: A healing solution for crises. Cambridge, MA: Perseus.Google Scholar
  6. Breggin, P. (2001). Talking back to Ritalin: What doctors aren't telling you about stimulants for children (Rev. ed.). Cambridge, MA: Perseus.Google Scholar
  7. Breggin, P. (2002). The Ritalin fact book. Cambridge, MA: Perseus.Google Scholar
  8. Carey, W. B. (2002). Is ADHD a valid disorder? In P. Jensen & J. Cooper (Eds.), Attention deficit hyperactivity disorder: State of science, best practices. Kingston NJ: Civic Research Institute.Google Scholar
  9. Cohen, D., Leo, J. L., Stanton, T., Smith, D., McCreedy, K., Laing, M. S., et al. (2002). A boy who stops taking stimulants for “ADHD”: Commentaries on a Pediatrics case study. Ethical Human Sciences and Services, 4, 189-209.Google Scholar
  10. DeGrandpre, R. (1999). Ritalin nation. New York: Norton.Google Scholar
  11. Diller, L. H. (1998). Running on Ritalin. New York: Bantam.Google Scholar
  12. Ford, J. D., Racusin, R., Daviss, W. B., Ellis, C. G., Thomas, J., Rogers, K., et al. (1999). Trauma exposure among children with oppositional defiant disorder and attention deficit-hyperactivity disorder. Journal of Consulting and Clinical Psychology, 67, 786-789.Google Scholar
  13. Ford, J. D., Racusin, R., Ellis, C. G., Daviss, W. B., Reiser, J., Fleischer, A., et al. (2000). Child maltreatment, other trauma exposure, and posttraumatic symptomatology among children with oppositional defiant and attention deficit hyperactivity disorders. Child Maltreatment, 5, 205-217.Google Scholar
  14. Green, M., Wong, M., Atkins, D., Taylor, J., & Feinleib, M. (1999). Diagnosis of attention deficit hyperactivity disorder. Rockville, MA: Agency for Healthcare Policy and Research.Google Scholar
  15. Hendrick, H. (1997). Constructions and reconstructions of British childhood: An interpretive survey, 1800 to the present. In A. James & A. Prout (Eds.), Constructing and reconstructing childhood: Contemporary issues in the sociological study of childhood (pp. 28-56). London: Falmer.Google Scholar
  16. Hynd, G. W., & Hooper, S.R. (1995). Neurological basis of childhood psychopathology. London: Sage.Google Scholar
  17. Joseph, J. (2000). Not in their genes: A critical review of the genetics of attention-deficit hyperactivity disorder. Developmental Review, 20, 539-567.Google Scholar
  18. Joughin, C., & Zwi, M. (1999). Focus on the use of stimulants in children with attention deficit hyperactivity disorder. Primary evidence-base friefing No.1. London: Royal College of Psychiatrists Research Unit.Google Scholar
  19. Jureidini, J., & Mansfield, P. (2001). Does drug promotion adversely influence doctors' abilities to make the best decisions for patients? Australasian Psychiatry, 9, 95-100.Google Scholar
  20. Kopelman, L. (1990). On the evaluative nature of competency and capacity judgements. International Journal of Law and Psychiatry, 13, 309-329.Google Scholar
  21. LeFever, G. B., Dawson, K. V., & Morrow, A. D. (1999). The extent of drug therapy for attention deficit hyperactivity disorder among children in public schools. American Journal of Public Health, 89, 1359-1364.Google Scholar
  22. Leo, J. L., & Cohen, D. A. (2003). Broken brains or flawed studies? A critical review of ADHD neuroimaging research. The Journal of Mind and Behavior, 24, 29-56.Google Scholar
  23. Mann, E. M., Ikeda, Y., Mueller, C. W., Takahashi, A., Tao, K. T., Humris, E., et al. (1992). Cross-cultural differences in rating hyperactive-disruptive behaviors in children. American Journal of Psychiatry, 149, 1539-1542.Google Scholar
  24. Moll, G., Hause, S., Ruther, E., Rothenberger, A., & Huether, G. (2001). Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters. Journal of Child and Adolescent Psychopharmacology, 11, 15-24.Google Scholar
  25. National Institutes of Health. (1998). Diagnosis and treatment of attention deficit hyperactivity disorder. Rockville, MD: Programs and abstracts, NIH Consensus Development Conference.Google Scholar
  26. Olfson, M., Marcus, S. C., Weissman, M. M., & Jensen, P. S. (2002). National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 514-521.Google Scholar
  27. Prout, A., & James, A. (1997). A new paradigm for the sociology of childhood? Provenance, promise and problems. In A. James & A. Prout (Eds.), Constructing and re-constructing childhood: Contemporary issues in the sociological study of childhood (pp. 1-27). London: Falmer.Google Scholar
  28. Postman, N. (1983). The disappearance of childhood. London: W.H. Allen.Google Scholar
  29. Rapoprt, J. L., Buchsbaum, M. S., Zahn, T. P., Weingartner, H., Lublow, C., & Mikkelsen, E. J. (1978). Dextroamphetamine: Cognitive and behavioral effects in normal prepubertal boys. Science, 199, 198-214.Google Scholar
  30. Rappley, M. D., Gardiner, J. C., Jetton, J. R., & Howang, R. T. (1995). The use of methylphenidate in Michigan. Archives of Pediatric and Adolescent Medicine, 149, 675-679.Google Scholar
  31. Schachter, H., Pham, B., King, J., Langford, S., & Moher, D. (2001). How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Canadian Medical Association Journal, 165, 1475-1488.Google Scholar
  32. Sonuga-Barke, E. J. S., Minocha, K., Taylor, E. A., & Sandberg, S. (1993). Inter-ethnic bias in teacher's ratings of childhood hyperactivity. British Journal of Developmental Psychology, 11, 187-200.Google Scholar
  33. Sproson, E. J., Chantrey, J., Hollis, C., Marsden, C. A., & Fonel, K. C. (2001). Effect of repeated methylphenidate administration on presynaptic dopamine and behavior in young adult rats. Journal of Psychopharmacology, 15, 67-75.Google Scholar
  34. Stephens, S. (1995). Children and the politics of culture in late capitalism. In S. Stephens (Ed.), Children and the politics of culture. New Jersey: Princeton University Press.Google Scholar
  35. Taylor, E., & Hemsley, R. (1995). Treating hyperkinetic disorders in childhood. BMJ, 310, 1617-1618.Google Scholar
  36. Timimi, S. (2002). Pathological child psychiatry and the medicalization of childhood. Hove, UK: Brunner-Routledge.Google Scholar
  37. Van Praag, H. M. (1996). Comorbidity (psycho) analysed. British Journal of Psychiatry, 168(Suppl. 30), 129-134.Google Scholar
  38. Zito, J. M., Safer, D. J., DosReis, S., Gardner, J. F., Boles, M., & Lynch, F. (2000). Trends in prescribing of psychotropic medications to preschoolers. JAMA, 283, 1025-1030.Google Scholar
  39. Zwi, M., Ramchandani, P., & Joughlin, C. (2000). Evidence and belief in ADHD. BMJ, 321, 975-976.Google Scholar

Copyright information

© Plenum Publishing Corporation 2004

Authors and Affiliations

  • Sami Timimi
  • 33 Coendorsers

There are no affiliations available

Personalised recommendations